E547 $43 a Test, $160M for the Lab: Why Select Sires and ABS Are Quiet on the GeneSeek Close

The Bullvine di The Bullvine

Note sull'episodio

Forty-three dollars buys one Clarifide Plus test. One hundred and sixty million bought the lab that runs it. Your co-op hasn't said a word about either.

Zoetis now sits at four points of leverage in the U.S. dairy genetics chain — the test, the index, the lab, and the processor partnership with Danone. As of May 1, 2026, none of the five major U.S. AI cooperatives most exposed to that shift has published a strategy response. The Bullvine Podcast walks through the full stack, the barn math, and the two questions every member-owner should be asking right now.

What You'll Learn

  • Why a $160M Zoetis–Neogen lab acquisition reshapes every co-op's negotiating position through 2030
  • How DWP$, NM$, and TPI weight methane, heat resilience, and wellness traits differently
  • The barn math on a 1,500-cow vs. 250-cow herd at $ ... 
 ...  Leggi dettagli
Parole chiave
genomic testingdairy genomics consolidationZoetis Neogen acquisitionDWP$ index updateA.I. industry strategyfarm data ownershipcooperative breeding plan